Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Millennium Pharma 3Q | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

Millennium Pharma 3Q

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Millennium Pharmaceuticals

3Q Revenues: $122 million (+18%)

3Q Loss: $1.7 million (loss of $13.7 million in 3Q06)

YTD Revenues: $346 million (flat)

YTD Loss: $26.2 million (loss of $52.2 million in YTD06)

Comments: U.S. net sales of Velcade grew 32% to $70 million in 3Q07 and royalty revenues were up 23% to $41.3 million. The company attributes some of its net YTD loss to amortization of intangibles ($34 million), stock-based compensation ($25 million) and restructuring charges ($15 million).

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters